Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Jun 23.
Published in final edited form as: J Nat Prod. 2025 Dec 11;88(12):3050–3064. doi: 10.1021/acs.jnatprod.5c01251

Sulfur-containing microbial natural products and their role in communal interactions

Katherine S Holandez-Lopez 1,#, Dan Xue 1,#, Conor Pulliam 1, Michael D Madden 1, Mingming Xu 1, Jie Li 1,*
PMCID: PMC13286621  NIHMSID: NIHMS2186829  PMID: 41378824

Abstract

Natural products remain a primary source of new chemical entities and a central medium of biological communication. Among them, sulfur-containing natural products from microbes stand out for their diverse motifs—such as thioether (S–Cα/β/γ), thiazole, and sulfonate groups—distributed across RiPPs, NRPs, polyketides, lipids, terpenoids, and hybrids. These sulfur-containing metabolites functionally contribute to communal interactions—intra- and interspecies microbe-microbe and microbe-host interactions—through their antibacterial, antifungal, antiviral, anticancer, and immunomodulatory activities. Crucially, they may act as information-rich signals that tune quorum circuits, biofilms, membrane and ion homeostasis, and host pathways. This review provides a structure- and mechanism-guided overview of sulfur-containing natural products reported over the past decade (2014–2025), covering their microbial sources, chemical diversity, and mechanisms of action, and emphasizing how sulfur functionality encodes interaction strategies from microbiomes to environmental systems.

Graphical Abstract

graphic file with name nihms-2186829-f0001.jpg

Introduction

Natural products produced by microorganisms are an important resource in drug discovery for their chemical diversity and facilitation of microbe-microbe and microbe-host communication.1–3 These information-rich small molecules advance strategies for competition, cooperation, and defense.

Within this landscape, sulfur-containing natural products occupy a particularly fertile niche.4–6 Sulfur is woven through a striking diversity of microbial metabolites that cut across biosynthetic logics—ribosomally synthesized and post-translationally modified peptides (RiPPs), non-ribosomal peptides (NRPs), polyketides (PKs), lipids, terpenoids, and hybrid assemblies. Their structural motifs span thioethers (S–Cβ/α/γ), thiazol(in)e rings and thiopeptide macrocycles, thiolactones, disulfides, sulfoxides and sulfones, as well as sulfonate and sulfate functionalities. This chemical latitude underpins both scaffold and function diversity.7 Sulfur-containing natural products display a broad spectrum of communal interactions, from antimicrobial to immunomodulatory effects, quorum sensing and quenching, biofilm modulation, membrane and ion homeostasis remodeling, and cross-kingdom host signaling.8,9 These compounds mediate behaviors within microbiomes that reverberate into environmental processes.

The past decade has seen a rapid expansion of this chemical and functional space. Genome and metagenome mining, targeted metabolomics, and advances in NMR/MS structure elucidation have uncovered new bond types and topologies in sulfur-containing natural products.10–12 In parallel, mechanistic work has connected discrete sulfur motifs to specific molecular outcomes—such as lipid reorganization, ion-homeostasis collapse, translational arrest, and toll-like receptor (TLR) pathway modulation—bridging genotype, chemistry, and phenotype.

This review reports the communal interactions induced by representatives from each major sulfur-containing natural product class discovered in the last decade (2014–2025). We proceed from their biological sources and chemical diversity to their activities and mechanisms, with emphasis on how sulfur moieties enable intra- and interspecies interactions within environmental microbial communities and within animal and human microbiome contexts. By integrating chemistry with mechanisms, we aim to provide a coherent framework that will guide discovery, functional annotation, and rational engineering of the next generation of sulfur-empowered natural products.

1. Ribosomally synthesized and post-translationally modified peptides (RiPPs)

Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a diverse and highly abundant superclass of natural products. RiPPs are first synthesized by the ribosome in the form of a precursor peptide (consisting of a leader and/or follower peptide and a core peptide) which is then modified by post-translational modification enzymes, ultimately yielding the mature RiPP after leader/follower peptide removal by a leader peptidase.13 Due to structural variation of the precursor peptide’s primary amino acid sequence and the numerous enzymatic modifications of the precursor peptide that are possible, RiPPs often possess highly distinct structures. Furthermore, because RiPP biosynthesis is largely dependent on the leader portion of the precursor peptide, the core peptide can be highly sequence diverse, even within the same RiPP subclass. The numerous sulfur-incorporating and sulfur-modifying post-translational modification enzymes involved in RiPP biosynthesis also enable the production of structurally diverse RiPPs. These post-translational modifications often directly contribute to the biological activities observed for RiPPs. In the subsections below, the chemical diversity and biological functions of RiPPs with different sulfur-containing functional groups are discussed.

1.1. Thioether containing RiPPs

Thioether crosslinks define a major tranche of RiPPs and are classified by the carbon atom bound to sulfur: S–Cβ, S–Cα, and S–Cγ (Figure 1 and Figures S1 and S2).13 These crosslinks hard-wire compact folds and precise binding surfaces, thereby determining membrane/lipid target recognition and, at the community scale, driving antagonism, colonization advantage, and signal interference.14–17

Figure 1.

Figure 1.

Structures of representative sulfur-containing RiPPs.

1.1.1. The S–Cβ thioether-containing RiPPs

The S–Cβ thioether-containing RiPPs are the most abundant and extensively characterized RiPP class, typically exemplified by lanthipeptides. In lanthipeptides, S–Cβ thioethers within (methyl)lanthionine bridges are generated via dehydration of serine and threonine residues into dehydroalanine (Dha) or dehydrobutyrine (Dhb), followed by intramolecular cysteine Michael addition, which builds multi-ring scaffolds.

Within this scaffold, recent studies reveal multiple modes of bioactivity and targets (Table 1). Nisin (1) (Figure 1 and Table 1) exemplifies a two-step, lipid II–dependent pore-forming mechanism in anti-Gram-positive bacteria: its N-terminal (methyl)lanthionine rings binding the pyrophosphate of lipid II, docking the peptide at the cell-wall interface; the C-terminal segment then inserts to nucleate lipid-II–stabilized pores, causing rapid membrane depolarization and bacterial death (Figure 2A).18–20 By contrast, cacaoidin (2) and nukacin ISK-1 (3) (Figure 1 and Table 1) illustrate non-porating routes inhibiting cell-wall synthesis: 2 binds lipid II and directly inhibits the transglycosylase (Figure 2A),21,22 whereas 3 primarily recognizing the pyrophosphate moiety of lipid II.23 In both cases, transglycosylation is blocked, thereby halting peptidoglycan polymerization and cell-wall synthesis in Gram-positive organisms (Figure 2A). A complementary strategy targets non-cell-wall lipids: cinnamycin (4) and duramycin (5) use three S–Cβ bridges to form a pocket that binds the phosphatidylethanolamine (PE) headgroup, leading to PE reorganization and selective permeabilization of PE-rich membranes.24–26 Cinnamycin (4) further induces transbilayer PE movement that facilitates the translocation and cell-surface exposure of annexin A2/A5,25 while 5 blocks TIM1-mediated entry of enveloped viruses by masking virion-associated PE26—extending this PE-targeting mechanism beyond bacteria.

Table 1.

Bioactive sulfur-containing RiPPs and the proposed targets

Compound(s) Sulfur-containing Group Species Activity Reference(s)
Nisin (1) S–Cβ thioether Lactococcus lactis Anti-Gram-positive strains (including MRSA); via lipid-II–stabilized pore formation 18–20
Cacaoidin (2) S–Cβ thioether Streptomyces cacaoi Anti-Gram-positive strains; via lipid-II sequestration and inhibition of cell wall transglycosylases. 21,22
Nukacin ISK-1 (3) S–Cβ thioether Staphylococcus warneri ISK-1 Anti-Gram-positive strains; via lipid-II sequestration blocks transglycosylation 23
Cinnamycin (4) S–Cβ thioether Streptomyces cinnamoneus Antimicrobial activity against PE-rich Gram-positives; via phosphatidylethanolamine (PE) binding and PE-dependent membrane permeabilization 24,25
Duramycin (5) S–Cβ thioether Streptomyces cinnamoneus Anti-Gram-positive strains; via PE headgroup recognition and selective permeabilization 26
Cebulantin (6) S–Cβ thioether Saccharopolyspora cebuensis Anti-Gram-negative strains 39
Salivaricin A2, B (7, 8) S–Cβ thioether Streptococcus salivarius Anti-inflammation; via STAT3 signaling inhibition 40
Salivaricin 10 (9) S–Cβ thioether Streptococcus salivarius Anti-Gram-positive strains; via lipid-II targeting; pThr-dependent immune modulation and antibiofilm 41
Sh-lantibiotic-α (10), Sh-lantibiotic-P (11) S–Cβ thioether Staphylococcus hominis Anti-Gram-positive strains (including MRSA) 42
Ruminococcin C (12) S–Cα thioether Ruminococcus gnavus Anti-Gram-positive strains; via membrane perturbation, rapid PMF/ATP collapse 43–45
Hyicin 4244 (13) S–Cα thioether Staphylococcus hyicus 4244 Anti-Gram-positive strains (include MRSA); via membrane action and form antibiofilm 46
Thuricin Z (14) S–Cα thioether Bacillus thuringiensis Anti-Gram-positive strains; via rapid membrane depolarization 47
Streptosactin (15) S–Cα thioether Streptococcus thermophilus Antimicrobial activity the producer strain and close Streptococcus relatives with the same BGC 48
Enteropeptin A (16) S–Cα thioether Enterococcus cecorum Antimicrobial activity against Enterococcus spp.; intra-genus antagonism 49
Thermocellin (17) S-Cγ thioether Clostridium thermocellum Roles in quorum sensing and metabolic control 50
Lactocillin (18) Thiazole Lactobacillus gasseri JV-V03 Antimicrobial activity against Staphylococcus aureus, Enterococcus faecium, Corynebacterium aurimucosum, Gardnerella vaginalis, and multiple Streptococcus species 59
Cutimycin (19) Thiazole Cutibacterium acnes Skin microbiome composition modulation, especially inhibition of Staphylococcus growth 60
Micrococcin P1 (20) Thiazole Bacillus cereus Biofilm matrix production upregulation in Bacillus subtilis 62
Staphylococcus caprae AIP (21) Thiolactone Staphylococcus caprae Inhibition of agr-mediated quorum sensing in Staphylococcus aureus 76
Figure 2.

Figure 2.

Sulfur-containing RiPPs responsible for mediating bacterial communal interactions. (A) Interactions occurring in environmental microbiomes. (B) Interactions occurring in the human microbiome.

Across recent additions to the S–Cβ thioether–containing RiPPs landscape (Table S1), including bicereucin,27 mathermycin,28 kyamicin,29 roseocin,30 lexapeptide,31 andalusicin,32 CMB001,33 bacinapeptins,34,35 balucin,36 lysinibacin,37 and kunkecin A38, antibacterial activity has been demonstrated predominantly against Gram-positive bacteria. Among these, kunkecin A, a nisin-type lantibiotic from Apilactobacillus kunkeei FF30–6 isolated from honeybees, exhibits narrow-spectrum yet potent activity against the honey bee pathogen Melissococcus plutonius38 In contrast, cebulantin (6), from Saccharopolyspora cebuensis, exhibits selective anti–Gram-negative activity, inhibiting outer-membrane–compromised Escherichia coli (ΔlptD) and several Vibrio strains (e.g., V. cholerae, V. parahaemolyticus).39

Beyond environmental and food-associated producer strains, the oral commensal Streptococcus salivarius produces salivaricin A2 (7) and salivaricin B (8), which interact with IL-6 and IL-21 to attenuate STAT3 signaling and thereby suppress STAT3-dependent inflammatory programs.40 The same species also produces a set of phosphorylated S–Cβ thioether–containing RiPPs collectively termed salivaricin 10 (9), including SrnA1, SrnA2, and SrnA4, which combine targeted antibacterial and antibiofilm activities with immune modulation. A conserved N-terminal phosphothreonine (pThr) residue is required to elicit neutrophil chemotaxis and phagocytosis and to bias macrophages toward an M2 phenotype.41 Sh-lantibiotic-α (10) and Sh-lantibiotic-β (11), from the skin commensal Staphylococcus hominis A9, show selective activity against Staphylococcus aureus (including methicillin-resistant strains, MRSA) and act synergistically with the human cathelicidin LL-37 against Staphylococcus aureus, while sparing common skin commensals.42

1.1.2. The S–Cα thioether-containing RiPPs

The S–Cα thioether linkages (sactionine) occur predominantly in sactipeptides (Figure 1). Such S–Cα linkages are installed by radical S-adenosylmethionine (rSAM) enzymes that couple the sulfur of an intramolecular cysteine to the α-carbon of another amino acid, thereby installing multiple sactionine thioether clamps of another amino acid.16 Although S–Cα–containing RiPPs constitute a relatively small family (Table 1),16 the past decade has seen rapid expansion in both membership and mechanistic insight. In 2019, ruminococcin C (RumC) (12) (Figure 1), from the human gut commensal Ruminococcus gnavus, was reported.43,44 Structurally, RumC departs from classical S–Cα–containing RiPPs by adopting an unnested, double-hairpin topology stabilized by four S–Cα linkages, rather than a single nested hairpin. RumC exhibits antibiotic activity against Gram-positive pathogens (e.g., Clostridium perfringens, Bacillus subtilis) and can also induce a lag phase for Gram-negative bacteria Escherichia coli, meanwhile it did not impact human cell viability. Recently, Shamseddine et al. demonstrated that RumC does not form stable large pores but instead rapidly collapses cellular energetics—ATP depletion and loss of the proton-motive force—supporting a membrane-perturbation–driven, non-pore mechanism that reconciles the earlier intracellular phenotypes.45 Additionally, Comparative analyses of the RumC isoforms reveal that differences in antibacterial potency (MIC) and spectrum correlate with subtle variations in their S–Cα crosslinking patterns.45

Other recently reported S–Cα-containing RiPPs reinforce this membrane-centric theme (Figure S2). Hyicin 4244 (13)46 from Staphylococcus hyicus displays anti-staphylococcal and antibiofilm activity consistent with membrane engagement. Thuricin Z (14)47 from Bacillus thuringiensis induces rapid bacterial membrane depolarization and primarily targets Gram-positive bacteria, with a narrow spectrum centered on the Bacillus cereus group. Subsequently, streptosactin (15)48 from oral Streptococcus spp. harbors two sequential four-residue sactionine macrocycles—an unusual, unnested topology within this family and shows potent but narrow activity restricted to the producer and its closest Streptococcus relatives that encode the same BGC, supporting a long-suspected fratricidal role in Streptococcus thermophilus populations. Enteropeptin A (16) from gut microbe Enterococcus cecorum introduces a thiomorpholine-type S–Cα thioether crosslink (with additional tailoring such as N-methylornithine) and exhibit intra-genus antagonism.49

1.1.3. The S–Cγ thioether-containing RiPPs

The S–Cγ thioether, installed by rSAM enzymes, represents an emerging linkage in RiPPs. Initial evidence for S–Cγ thioether formation in RiPPs came from a distinctive class of precursor peptides termed SCIFF (Six Cysteines In Forty-Five), characterized by approximately six cysteines within a conserved C-terminal region of about 45-residue in the precursor.50 An unambiguous S–Cγ chemistry was established in 2019 by Hudson et al. for the SCIFF peptide thermocellin (17) (Figure 1 and Table 1) from Clostridium thermocellum.50 Functionally, SCIFF-derived ranthipeptides have been implicated in quorum sensing and metabolic control in solventogenic clostridia, suggesting an in situ signaling role for S–Cγ scaffolds.51 Recently, genome–metagenome surveys indicate that SCIFF/ranthi-like gene cassettes and SPASM-domain rSAM pathways are widespread and enriched in gut niches (e.g., Clostridia), yet only a limited set of S–Cγ products has been chemically validated to date.52–55

1.2: Thiazol(in)e-containing RiPPs

Thiopeptides are a class of sulfur-rich RiPPs which contain several thiazol(in)e residues, in addition to a pyridine moiety, which collectively form a peptide with a macrocyclic region and a short tail region.56 They are biosynthesized via YcaO-dependent cyclodehydration of a precursor peptide to form the thiazol(in)e moieities, followed by LanB-like dehydration of Ser/Thr to form Dha/Dhb residues and subsequent [4+2] cycloaddition of two Dha residues to form the pyridine ring, which completes the macrocycle prior to leader peptide cleavage.57 Thiopeptides have complex structures and have been identified throughout nature, including in the human microbiome. Indeed, one of the founding bioinformatic studies of human microbiome-derived secondary metabolites identified diverse thiopeptide BGCs in metagenomic data throughout different anatomical regions of the human microbiome.58 This included the thiopeptide antibiotic lactocillin (18) derived from the genome of Lactobacillus gasseri JV-V03, an isolate from the human vaginal microbiome. Compound 18 demonstrated nM minimum inhibitory concentration (MIC) against several notable human pathogens, including Staphylococcus aureus, Enterococcus faecium, Corynebacterium aurimucosum, Gardnerella vaginalis, and multiple Streptococcus species. Interestingly, Lactobacillus spp. are the most highly isolated bacterial species from the healthy human vagina.59 Thus, the potent inhibitory activity of 18 against numerous pathogens may suggest that 18 plays an important role in combating vaginal bacterial infections and maintaining a healthy vaginal microbiome. Other thiopeptides have also been shown to contribute to interspecies competition in the human microbiome. Cutimycin (19), a thiopeptide from the abundant skin-associated Cutibacterium acnes, was shown to modulate the skin microbiome composition, particularly by inhibiting the growth of Staphylococcus, a bacterial genus that is also abundant in the skin microbiome.60 Thiopeptides have also been found in other animal microbiomes, including in bacterial symbionts of fungus-gardening Trachymyrmex ants, where they likely play a role in combating ant pathogens.61 Besides their roles as antibiotics in interspecies warfare, thiopeptides have also been implicated in signaling-related activities (Figure 2A). A group of thiopeptide antibiotics known as thiocillins from Bacillus cereus were previously shown to induce biofilm matrix production in Bacillus subtilis.62 This included the thiocillin micrococcin P1 (20), which, like other thiopeptides, also possessed antimicrobial activity via inhibition of translation.63,64 Importantly, however, the antibiotic activity and biofilm induction activity of thiocillins were shown to be independent of each other, as a mutated 20 that lost its antibiotic activity due to the mutation was shown to retain its biofilm induction activity. Furthermore, other bacteria that contained thiopeptide BGCs in their genomes were also shown to be capable of inducing B. subtilis biofilm matrix production during coculture with B. subtilis. This intriguing discovery suggested that 20, and likely numerous other thiopeptides, are capable of interacting with multiple targets, including the ribosome to exert antimicrobial activity as well as other non-ribosomal targets to influence biofilm production.

1.3: Thiolactone-containing RiPPs

Besides their roles in direct interspecies competition in microbiomes, RiPPs can have more indirect effects on the populations of other microbes. One such class of non-antibiotic RiPPs that influences nearby microbes is the class of autoinducing peptides (AIPs). AIPs are short peptides 7–12 amino acids in length which contain a lactone or thiolactone cyclization, forming a five-residue macrocyclic structure.65,66 AIPs have been identified across diverse bacterial phyla, with bioactivities including pathogenic biofilm inhibition and modulation of microbiome composition against pathogenic species such as those from the genera Paramuribaculum, Oscillospiraceae, Heminiphilus, and Prevotella.53 However, the most well-studied AIPs are those from Staphylococcus spp., particularly Staphylococcus aureus. There are four known AIPs produced by S. aureus – AIP-I through AIP-IV – which all contain a thiolactone formed between a Cys residue and the C-terminal carboxylate. S. aureus AIPs are well-known for their roles in quorum sensing via the activation of the agr operon in S. aureus, which contributes to global upregulation of virulence factors.67–71 The role of S. aureus AIPs in quorum sensing and controlling virulence is arguably more influential to microbial populations than the influence of antimicrobial metabolites, as the upregulation of virulence genes in Staphylococcus spp. enables their survival and overcolonization in the human microbiome, which not only allows for initial infection, but can contribute to recurrent infections.72–75 Conversely, however, AIPs secreted by other Staphylococcus species (non-cognate AIPs to S. aureus) have been shown to downregulate virulence in S. aureus. The AIP from Staphylococcus caprae (21) – which contains a thiolactone formed between C4 and F8 of the peptide (YSTCSYYF) – was shown to inhibit agr-mediated quorum sensing in S. aureus, which contributed to the prevention of methicillin-resistant S. aureus (MRSA) infections from progressing in a mouse model.76 This interspecies regulatory activity of 21 acting on S. aureus is distinct from the activity of native S. aureus-produced AIPs, such as AIP-I (YSTCDFIM), in controlling S. aureus virulence, demonstrating the biological versatility of thiolactone-containing AIPs (Figure 2B).

2. Non-ribosomal peptides (NRPs)

Through incorporation of non-proteinogenic amino acids, non-ribosomal peptides (NRPs) offer expanded structural diversity compared to their ribosomally synthesized counterparts, and a broad range of activities.77 NRPs typically acquire their sulfur through the incorporation of methionine or cysteine, as specified by an adenylation (A) domain of NRP synthetase (NRPS). A cysteine residue may be acted on by a cyclization (Cy) domain to form thiazoline heterocycles, which may be oxidized to form thiazoles or reduced to form thiazolidines. Alternatively, tailoring enzymes acting upon the NRP in trans (i.e. outside of the canonical NRPS) can bestow unique sulfur-containing groups such as thioketones and acylsulfenic acid.78,79

NRPs are often employed for defensive action, such as through antibacterial or antifungal activities. In the human microbiome, some antimicrobial NRPs additionally modulate the host immune response to combat invading species. Also common are NRP metallophores used for metal homeostasis and to outcompete other organisms in metal-limited environments. In many of these cases, the sulfur moiety of these compounds plays an important role in target recognition and metal chelation.80,81 This section will highlight recently discovered examples of sulfur-containing NRPs and polyketide-NRP hybrids (PK-NRPs) (Figure 3) and their diverse communal activities (Table 2).

Figure 3.

Figure 3.

Chemical structures of representative NRPs and PK-NRPs.

Table 2.

Sulfur-containing NRPs and PK-NRPs and their activities as described in this section.

Compound(s) Sulfur-containing group Species Activity Reference(s)
Bacillothiazols (22–26) Polythiazole Bacillus velezensis FZB42 PTP1B inhibitor; implicated in Bacillus swarming 83
Mupirochelin (27) Thiazole, thiazoline Pseudomonas sp. NCIMB 10586 Metallophore; anti-oomycete activity 84
Mutanobactins (28), mutanolins Thiazepanone Streptococcus mutans UA159 Inhibits hyphal formation of Candida albicans; induces cytokine (IL-6, IL-12) release 87–89
Mutanofactins (29) Thiazole Streptococcus mutans Promotes intra- and interspecies biofilm formation 90,91
Lugdunin (30) Thiazolidine Staphylococcus lugdunensis Anti-Gram-positive activity via membrane breakdown; TLR2 agonist 92,93
Sadopeptin A, B (31, 32) Methionine sulfoxide (S=O) Streptomyces sp. YNK18 Proteasome inhibitor 94
Ecteinamines (33, 34) Methionine sulfoxide, sulfanediol, thiazoline Micromonospora sp. WMMB482 Broad-spectrum metallophore 95
Sulfenicin (35) Acylsulfenic acid, thiazole Streptomyces sp. CNT360 Broad-spectrum metallophore 79
Thiolactomycin (36) Thiolactone Lentzea sp. ATCC 31319 Anti-Gram-positive, anti-Gram-negative, anti-protozoal activity via type II fatty acid synthase inhibition 96,97
Forazoline A (37) Thioketone (S=C), thiazoline Actinomadura sp. WMMB-499 Antifungal activity via membrane permeabilization 78,98
Collismycin A, C (38, 39) Methyl sulfide (S-CH3) Streptomyces sp. MC205, S. sp. MQ22 Anti-cancer and anti-biofilm activity via metal starvation (metallophore) 99,100

2.1. S,N-heterocycle-containing NRPs

Thiazole-producing NRPS biosynthetic gene clusters (BGCs) often encode bioactive molecules, which make them good search targets for BGC prediction tools such as antiSMASH.82 Bacillothiazols (22–26) from the rhizobacterium Bacillus velezensis FZB42 were recently discovered via this method. These compounds feature three consecutive thiazoles that are oxidized iteratively by the tailoring enzyme NrsB, as opposed to in cis oxidase domains. Bacillothiazols were found to be strong inhibitors of protein tyrosine phosphatase PTP1B. Additionally, heterologous expression of the bacillothiazol BGC, nrs, in B. subtilis resulted in reduced swarming, hinting at the potential activity of the compound in its native strain.83 Another intriguing polythiazole-containing NRP is mupirochelin (27), produced by soil bacterium Pseudomonas sp. NCIMB 10586. This compound has moderate iron-chelating activity, but when not complexed with metal ions, it also displays anti-oomycete activity against Globisporangium ultimum, a pathogen found in the bacterium’s native environment.84 From the human microbiome, it was recently discovered that Streptococcus salivarius K12 produces thiazolidine-containing PK-NRPs termed salivabactins with potent bactericidal activity against Gram-positive strains, though the exact mechanism is currently unclear.85,86

In the human oral microbiome, Streptococcus mutans UA59 produces mutanobactins and mutanolins to combat the colonization of pathogenic fungus Candida albicans.87–89 These PK-NRP hybrids, characterized by their unique seven-membered thiazepanone ring, were found to inhibit the transition of C. albicans from its yeast form to its invasive mycelial form. Additionally, mutanobactin B (28) was found to significantly promote the release of pro-inflammatory cytokines IL-6 and IL-12 from human macrophages (Figure 4), yet decreases release of other such cytokines such as MCP-1 and G-CSF. This activity is specific to the sulfur-containing peptide portion of mutanobactin, as it is not displayed by the mutanamide intermediate, which lacks the cysteine moiety.89 These results warrant further study of the role immunomodulation by mutanobactins may play in combating C. albicans. S. mutans also produces NRPs to promote the biofilm formation of itself and related human commensal species Streptococcus gordonii and Streptococcus oralis, namely the thiazole-containing mutanofactin (Muf) family. Muf-697 (29) in particular was found to alter the morphology of the hydrophilic mucin layer that protects the oral cavity, exposing the hydrophobic surface and allowing for increased bacterial adhesion. This activity works in tandem with the biofilm-promoting effects of mutanofactins to establish S. mutans as an early colonizer of the human oral microbiome.90,91

Figure 4.

Figure 4.

Models of sulfur-containing NRPs mutanobactin B (28) and lugdunin (30) from human commensals being used to combat invading species. In the oral microbiome, Streptococcus mutans produces mutanobactin B (28) to inhibit the transition of Candida albicans to its invasive hyphal form and induce pro-inflammatory cytokine release from macrophages. In the skin microbiome, lugdunin (30) is released by Staphylococcus lugdunensis to kill S. aureus, work cooperatively with human AMPs, and induce cytokine release from primary human keratinocytes.

Similarly to mutanobactins from S. mutans, Staphylococcus lugdunensis produces the NRP lugdunin (30) to combat Staphylococcus aureus in the human skin and nasal microbiomes.92,93 Lugdunin, a macrocyclic peptide containing a thiazolidine ring, is a potent bactericidal agent against S. aureus and other Gram-positive bacteria. This effect is cooperative with human antimicrobial peptides (AMPs) such as LL-37 and DCD-1(L), and lugdunin increases the expression of these host AMPs. In addition, lugdunin was found to induce release of pro-inflammatory cytokines from several cell types—for instance, induction of CXCL8 release via interaction with toll-like receptor 2 (TLR2) on primary human keratinocytes—leading to the recruitment of neutrophils and monocytes. The combination of direct killing, cooperativity with host AMPs, and the action of phagocytic immune cells prevents S. aureus colonization.93 These examples of mutanobactin B (28) and lugdunin (30) showcase how multifunctional, sulfur-containing NRPs can be used by human commensal bacteria to mobilize the host immune system (Figure 4).

2.2. S-O bond-containing NRPs

A wide variety of sulfur-containing functional groups can be added to an NRP in trans, such as those with sulfur-oxygen bonds. For instance, the recently discovered NRP families of sadopeptins (31–32) and ecteinamines (33–34) contain methionine sulfoxide (Met(O)), among other uncommon functional groups.94,95 Sadopeptin A and B (31–32) were isolated from Streptomyces sp. YNK18 after a targeted search for mass spectroscopic signatures of sulfur-bearing compounds. 31 and 32 were found to be potent proteasome inhibitors with a distinct effect compared to known inhibitors that did not involve autophagic flux or apoptosis, thus suggesting potential use as antimicrobial compounds.94 Ecteinamines P and A (33–34) produced by marine bacterium Micromonospora sp. WMMB482 feature sulfanediol (33), thiazoline, and Met(O) (34) groups. They were found to be broad-spectrum metallophores, chelating iron, copper, nickel, zinc, and cobalt.95 Another intriguing S-O functional group, acylsulfenic acid, was recently found to be naturally synthesized by marine Streptomyces sp. CNT360 in the PKNRP sulfenicin (35). The biosynthetic S-hydroxylation enzyme (TaaH) is broadly distributed across bacterial phyla, including in four other BGCs, indicating the group may be an important structural feature of multiple natural products. 35 appears to function as a broad-spectrum metallophore, and further investigations into its biological activity are ongoing.79 As with the previously discussed with mupirochelin (27), it is possible these complex metallophores have additional interactions with specific competitors in the producing organism’s native environment.

2.3. Other sulfur-containing NRPs

Some known sulfur-containing NRPs have only recently had their biosynthesis or bioactivities elucidated. For instance, the unique γ-thiolactone ring of antibacterial thiolactomycin (36) was determined to be synthesized via an unusual sulfuration by an NRPS Cy domain (TlnCCy) and subsequent cyclization by a cytochrome P540 enzyme (TlnA).96 Thiolactomycin specifically inhibits type II fatty acid synthase FabB/FabF, thus giving it potent activity against Gram-positive and Gram-negative bacteria, and protozoans (e.g. Plasmodium falciparum, Trypanosoma brucei). The γ-thiolactone ring is essential to this activity, as it mimics the orientation of the thiomalonate substrate required for fatty acid synthesis.97 Forazoline A (37) is a novel PK-NRP antifungal from Actinomadura sp. WMMB-499 that was initially predicted to contain a sulfoxide group, but a revision of the mass spectrometry data revealed it contained a unique thioketone group instead.78 Forazoline A causes permeabilization of the fungal membrane and has synergy with antifungal compound amphotericin, indicating a distinct mechanism of action.98 Lastly, the methyl-sulfide-containing collismycins (38, 39) have been extensively studied for their diverse bioactivities. For example, collismycin C (38) has been shown to inhibit biofilm formation of S. aureus, while collismycin A (39) inhibits proliferation of cancer cells. Both activities have been linked to the iron-chelating activity of collismycins, as they limit the iron that is available for cell growth.81,99,100 Such studies showcase the versatility of sulfur-containing NRPs, allowing their native producers to outcompete other species both by direct (e.g. antibacterial, antifungal) and indirect (e.g. immunomodulatory, metal-starving) interactions.

3. Polyketides (PKs) and Lipids

Though sulfur incorporation is relatively less common than in peptides, the well-established signaling properties of polyketides and lipids translate to their sulfur-containing analogs.101–103 Sulfur incorporation in these compounds can come from a variety of sources, including but not limited to amino acids, enzymatic sulfation, and sulfur-containing small molecules.104–107 The varied signaling activities of these sulfur-featuring molecules reflect their structural diversity (Figure 5). Though these compounds may be sourced from environmental microbiomes (e.g. endophytic, marine) in addition to the human microbiome, modulation of the human immune system is a common target for lipid and PK-based drug discovery, with the anti-inflammatory activities of prunomarin A (40) and rubterolone N (42) exemplifying this trend.108,109 Besides this route, neosartyone (41) can inhibit lipid accumulation in HepG2 liver cells and oxazolismycin (43) has been explored as a potential treatment for high blood pressure as an angiotensin-converting enzyme (ACE) inhibitor.110,111 These promising activities warrant further elucidation of the affected signaling mechanisms, which will be explained through the remainder of this section. The next paragraphs, organized by the featured chemical bond, will highlight several prominent sulfur-containing lipids and polyketides and explore their signaling activities in detail (Figure 6).

Figure 5.

Figure 5.

Representative structures of sulfur-containing PK and lipid signaling natural products.

Figure 6:

Figure 6:

Highlighted sulfur-containing PKs and lipids and their signaling activities. The color blocks correspond to the source of the producing strain. RNS: reactive nitrogen species.

3.1. Thioether and Sulfoxide-containing PKs

A large-scale screening study of 5,000 fungal samples using a Signal Transducer and Activator of Transcription 3 (STAT3) activity assay carried out by Li et. al. identified a fraction generated from Paraphaeosphaeria neglecta FT462, fungus that resides in the Hawaiian plant Lycopodiella cernua, which exhibited notable STAT3 inhibition. Bioassay-guided fractionation led to the isolation of three novel metabolites, including one that featured a rare γ-pyranone–γ-lactam–1,4-thiazine skeleton, termed paraphaeoispearide A.112 Although this sulfur-containing polyketide was not attributed to the observed STAT3 inhibition, a subsequent study revealed two additional sulfur-containing derivatives, paraphaeoispearides E and G (44 and 45).113 As opposed to the heterocyclic thiazine moiety seen in paraphaeospearide A, the sulfur atoms in 44 and 45 were instead situated on a mercaptolactate-derived backbone. In 44, this sulfur appeared as a sulfide, while 45’s sulfur featured as a sulfoxide. 44 and 45 both downregulated the expressions of nuclear factor-κB (NF-κB) and inducible nitric oxide synthase (iNOS) without notable cytotoxicity, suggesting an important role of the linear geometry of the sulfur-containing moieties to enable their signaling properties. 45’s increased potency against NF-κB and iNOS further emphasized the potential role of the sulfoxide group in mediating these immunological phenomena (Figure 6).113 The fundamental role of NF-κB signaling to induce inflammation suggest that 44 and 45 could be promising candidates as immunomodulatory drugs, such as chemopreventative drugs.

3.2. Disulfide-containing PKs

Han et. al. employed modified culture parameters to induce the production of dipenirestones which feature disulfide-linked resorcylic acid lactones (RALs). These sulfur-linked dimers, which were produced through the addition of DMSO and sea salt to a marine Pencillium sp. culture, exhibited notable anti-proliferative activity and apoptosis in the human gastric cancer cell line HGC-27, prompting further investigation into their anti-cancer activity. Depenirestone A (46) was found to arrest the cell cycle in the HGC-27 cells, leading to investigations into its effects on the P13K/AKT/mTOR signaling pathway due to its important role in mediating cell survival, proliferation, and cell cycle progression.107 Molecular docking simulations suggested that 3 could strongly interact with P13K and western blotting confirmed that both RAL dimers could inhibit the activation of P13K, AKT, and mTOR to induce their anti-proliferative effects. These results were corroborated by reduced cell cycle regulatory protein (Cyclin E and Bcl-2) and increased apoptotic marker (Cleaved Caspase 3 and Bax) expressions, illustrating an elaborate signaling cascade influenced by 46 that intertwines cell cycle arrest and apoptosis to induce an anti-cancer effect (Figure 6).107

3.3. Sulfonate-containing Lipids

As microbial mimics of human endogenous sphingolipids, sulfonate-containing bacterial sulfonolipids (SoLs) have been established as important mediators of Toll-like Receptor 4 (TLR4)-mediated inflammation in human disease. An earlier elucidated the unique biosynthetic enzymes underlying SoL production, namely a cysteate synthase (Cys), a cysteate fatty acyltransferase (CFAT), and a short-chain dehydrogenases/reductase (SDR).114,115 Biosynthetic enzyme-guided correlation of these enzymes using multi-omic gut microbiome data from inflammatory bowel disease (IBD) datasets found a consistent negative correlation with the abundance of SoL-producing bacteria (e.g., Alistipes, Chryseobacteriun, and Odoribacter), SoL-synthesizing enzymes, and SoL abundance, which was confirmed in an IL10−/− and proxicam-induced colitis mouse model.115,116 Given their structural similarities to lipid A, the immunogenic component of lipopolysaccharide, (LPS), prompted their investigations in mediating TLR4-dependent signaling. Molecular docking of sulfobacins A and B (47 and 48) supported the binding of multiple SoLs to the TLR4/MD-2 complex, which was confirmed with an ELISA displacement assay.115 While SoLs could induce mild IL-6, TNFα, and IL-1β gene expressions when administered alone, Co-treatment with LPS saw a dramatic decrease in inflammatory cytokine expression compared to LPS treatment. Further western blotting found that SoL treatment decreased LPS-induced ERK1/2 and p38 expressions and IκBα degradation, all of which occur downstream of the TLR4 signaling (Figure 6).114,115 Besides influencing this pathway to mitigate host gut disease-related inflammation, a subsequent study also found that colonization by SoL-producing bacteria could modulate the host lipidome, potentially enabling further protective signaling effects outside TLR4.116 Collectively, these studies established an emerging class of immunoregulatory sulfonate-containing lipids produced by human microbiota that protect against gut inflammation.

3.4. Sulfate-containing Lipids

In contrast to the anti-inflammatory activity of the sulfobacins, the sulfur-containing glycolipid sulfolipid-1 (49) produced by pathogenic Mycobacterium tuberculosis strains has been garnering attention as a potential virulence factor. The sulfate group is installed on a trehalose by sulfotransferase (Stf0) prior to extensive acylation reactions.117 As the causative agents of pulmonary tuberculosis, Ruhl et. al. found that M. tuberculosis and organic extracts of the bacteria could induce cough in guinea pigs. Non-virulent strains that did not produce 49 could not replicate these results, prompting their investigation into 49’s potential cough-inducing mechanism. Besides increasing cough in guinea pigs upon nebulization, 49 could activate mouse and human dorsal root ganglion (DRG) and nociceptive neurons, as indicated by dramatically increased intracellular [Ca2+] following treatment. This increase occurred at the same level in Ca2+-free media, thus suggesting that the influx of Ca2+ was derived from intracellular pools. These results were only observed in capsaicin-responsive neurons expressing transient receptor potential cation channel subfamily V member 1 (TRPV1+). These combined results suggest that 49 can agonize TRPV1 and promote Ca2+ influx into TRPV1+ neurons to induce cough during M. tuberculosis infections (Figure 6).117 The characterization of 49’s cough-inducing activity presents a novel aspect of M. tuberculosis infection pathogenesis that can be targeted in future drug development programs.

4. Terpenes and Others

4.1. Terpenes

The incorporation of sulfur into terpenoids is relatively less common compared to ribosomal peptides (RiPPs), non-ribosomal peptides (NRPs), and polyketides (PKs). However, recent studies have unveiled a series of structurally unique sulfur-modified terpenoids with significant biological functions (Figure 7 and Table 4). These compounds, primarily isolated from endophytic and marine fungi, play a crucial role in mediating their bioactivities. In many cases, the biosynthetic enzyme or method for incorporation of sulfur into these rare compounds is unknown or unclear.6,101

Figure 7:

Figure 7:

Representative structures of sulfur-containing terpenes and other signaling natural products.

Table 4.

Sulfur-containing terpenes and others with bioactivities

Compound(s) Class Sulfur-containing Group Species Activity Reference(s)
Leptosphin A (50) Terpenes Sulfide Leptosphaeria sp. XL026 Antimicrobial activity against Rhizoctonia cerealis and Bacillus cereus 118
Pseudallenes A (51) and B (52) Terpenes Sulfide Pseudallescheri a boydii CS-793 Plant pathogen inhibition against Gaeumannomyces graminis, Colletotrichum gloeosporioides, Alternaria solani 119
(7S)-flavilane A (53) Terpenes Sulfoxide Aspergillus sydowii 10–31 Microalgae inhibition against Prorocentrum sp.; anti-Gram-negative activity against Vibrio sp. 120
(7S)-4-iodo-flavilane A (54) Terpenes Sulfoxide Aspergillus sydowii 10–31 Microalgae inhibition against Prorocentrum sp.; anti-Gram-negative activity against Vibrio sp. 120
Ovothiol A (55), B (56), and C (57) Others Thiol Sea urchin eggs, marine organisms, including invertebrates, microalgae, and bacteria. Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and photoprotective activities; redox homeostasis (GSH cooperation), photochemical reduction, oxidative stress regulation (↑GSH, ↑CAT, ↓MDA, ↓NO), modulation of NF-κB and apoptotic signaling pathways 121–125
Violaceimides A-D (58–61) Others Sulfide Aspergillus violaceus Selective inhibitory effects against human leukemia U937 and human colon cancer HCT-8 cells 126
Ochrathinols A and B (62, 63) Others Sulfide Aspergillus ochraceopetalif ormis Anti-inflammatory activity by suppressing pro-inflammatory cytokine (IL-1β, IL-6, and TNF-α) release and restoring NAD+/NADH balance 127
Tropodithietic acid (64) Others Disulfide Phaeobacter inhibens and P. piscinae Broad-spectrum antibacterial activity; disturb metabolic and stress-response pathways in target bacteria, inducing oxidative-stress and iron-uptake genes; regulates gene networks associated with motility, biofilm formation, and secondary metabolism; reshape microbial community composition and contribute to ecological stability 128–130

4.1.1. Sulfide-containing Terpenes

Leptosphin A (50) is a novel sulfur-containing sesquiterpenoid isolated from the endophytic fungus Leptosphaeria sp. XL026, representing the first example of a sulfur-substituted eremophilane sesquiterpenoid. It exhibits moderate antibacterial activity against the plant pathogens Rhizoctonia cerealis and Bacillus cereus, providing a new scaffold for the discovery of novel antimicrobial agents.118 Pseudallenes A (51) and B (52) are two new sulfur-containing ovalicin sesquiterpenoid derivatives discovered from the deep-sea cold seep fungus Pseudallescheria boydii CS-793. These compounds are exceptionally rare examples of sulfur-modified ovalicin derivatives, which showed broad-spectrum inhibitory activity against various plant pathogens, including Gaeumannomyces graminis, Colletotrichum gloeosporioides, and Alternaria solani, with MIC values ranging from 2 to 16 μg/mL.119

4.1.2. Sulfoxide-containing Terpenes

The cold-seep fungus Aspergillus sydowii 10–31 yielded two rare sulfoxide-containing sesquiterpenoids, namely the known (7S)-flavilane A (53) and the new (7S)-4-iodo-flavilane A (54). Notably, compound 54 is unique due to its incorporation of an iodine atom. These compounds demonstrated inhibitory effects against the harmful microalgae Prorocentrum micans and Prorocentrum minimum, as well as the bacteria Vibrio anguillarum, Vibrio harveyi, Vibrio parahaemolyticus, and Vibrio splendidus.120

4.2. Others

4.2.1. Thiol-containing Others

Ovothiols, particularly ovothiol A (55), B (56), and C (57), are a unique class of sulfur-containing natural products. The most notable structural feature of these compounds is the 5-thiolhistidine moiety, a histidine ring containing a thiol group (Figure 7). First isolated from sea urchin eggs, they are now found in a wide range of marine organisms, including invertebrates, microalgae, and bacteria. The widespread distribution of ovothiols and their distinct chemical properties suggest that they play a central role in the cellular biochemistry and survival of marine ecosystems. While ovothiols are far from being simple antioxidants, their unique structure allows them to act as versatile molecular messengers, subtly regulating communal interactions both within and between cells, and even across different species. For instance, their oxidized forms can directly inhibit key metabolic enzymes in microalgae, indicating their role as molecular switches in a cell’s response to environmental signals like light.121

In terms of redox homeostasis, the low pKa thiol group of ovothiols makes it an efficient antioxidant, capable of rapidly scavenging reactive oxygen and nitrogen species (ROS/RNS) to protect cells from oxidative damage. Its unique redox potential allows it to form a sophisticated cooperative system with glutathione (GSH), where ovothiols quickly eliminates peroxides, and the resulting ovothiols disulfide can then be reduced by the more potent GSH.122 Recent research has also unveiled the photochemical reduction properties of ovothiols: their disulfide form can be converted back to the reduced form upon exposure to UVA light. The reduced form exhibits stronger UVA absorption and a barrier effect, thereby reducing UVA-induced oxidative damage to proteins and lipids.121,123 These findings reveal the multifaceted roles of ovothiols in environmental stress response and intracellular signaling.

The unique chemical and biological functions of ovothiols have opened up significant prospects in pharmacology. Recent studies have confirmed their powerful antioxidant and anti-inflammatory activities, exploring their therapeutic potential in various disease models. In a rat myocardial infarction model induced by epinephrine, oral administration of ovothiol A significantly improved electrocardiogram abnormalities and restored a variety of biomarkers by enhancing antioxidant indicators like GSH and catalase (CAT) while reducing oxidative stress markers such as malondialdehyde (MDA) and nitric oxide (NO).121,124 Similarly, in an ethanol-induced rat gastric ulcer model, ovothiol A promoted ulcer healing by scavenging free radicals, inhibiting inflammation, and regulating cell apoptosis.125 The consistency across these studies suggests that the core therapeutic mechanism of ovothiols in various disease models is closely linked to their potent antioxidant and anti-inflammatory capabilities (Figure 8A).

Figure 8.

Figure 8.

Other sulfur-containing natural products responsible for mediating bacterial communal interactions. (A) Thiol-containing others and their proposed signaling activities; (B) Disulfide-containing others and their proposed signaling activities.

4.2.2. Sulfide-containing Others

Violaceimides A-D (58-61), from the sponge-associated fungus Aspergillus violaceus, demonstrate selective inhibitory effects against human leukemia U937 and human colon cancer HCT-8 cells, with low cytotoxicity to Vero cells, highlighting their potential as therapeutic agents.126 Also classified as thioethers are ochrathinols A and B ((±)-62 and (±)-63), a pair of previously unreported sulfur-containing racemates isolated from the antarctic soil fungus Aspergillus ochraceopetaliformis.127 These compounds have a novel structure featuring a 3-methylhexahydro-2H-cyclopenta[b]thiophene core. Interestingly, ochrathinol A ((±)-65) remarkably suppressed the release of LPS-induced pro-inflammatory cytokines (such as IL-1β, IL-6, and TNF-α) at a concentration of 10 μM. It also effectively alleviated the unbalanced NAD+/NADH ratio caused by LPS in RAW264.7 macrophages, demonstrating strong anti-inflammatory activity.

4.2.3. Disulfide-containing Others

Tropodithietic acid (TDA, 64), a sulfur-containing seven-membered aromatic natural product produced by members of the marine family Rhodobacteraceae (such as Phaeobacter inhibens and P. piscinae), exhibits broad-spectrum antibacterial activity. It effectively inhibits several marine and opportunistic pathogens, including Vibrio anguillarum, V. vulnificus, and Pseudomonas aeruginosa.128 Recent studies have further revealed that sub-inhibitory concentrations of TDA disturb metabolic and stress-response pathways in target bacteria, notably inducing oxidative-stress and iron-uptake genes.129 Beyond its antimicrobial effect, TDA acts as a signaling molecule within its producers and neighboring microbes. Transcriptomic analyses demonstrated that TDA regulates gene networks associated with motility, biofilm formation, and secondary metabolism, largely overlapping with those controlled by acyl-homoserine lactone quorum-sensing systems, suggesting a coordinated regulatory interplay.128,130 Moreover, TDA has been shown to reshape microbial community composition and contribute to ecological stability, underscoring its dual role as both an antibiotic and a chemical signal in marine microbial ecosystems (Figure 8B).128

Conclusion

This review consolidates discoveries from the past decade in microbial sulfur-containing natural products across RiPPs, NRPs, polyketides, lipids, terpenoids, and hybrids that regulate various communal interactions. Across these classes, the mechanisms converge on high-value nodes of cellular physiology and communication: lipid II and membrane engagement, ribosomal and translation inhibition, ion-homeostasis and envelope remodeling, quorum-circuit rewiring and biofilm control, host immune modulation, and metal/redox homeostasis interference. This breadth positions these sulfur-containing metabolites as candidates for new anti-infectives, antivirals, immunomodulators, and adjuvants, as well as precision tools for perturbing microbiomes. The last decade has seen advancements in genomic mining tools that enable the targeting of BGCs encoding sulfur moieties, and improved methodologies for identifying and isolating sulfur-containing natural products by their specific spectroscopic signals. As drug discovery technologies continue to advance, sulfur-containing natural products remain a relevant and diverse source of bioactive and signaling compounds with potent therapeutic potential.

Supplementary Material

Supporting Information

Additional compound structures (Figure S1, S2) and biological information (Table S1) (DOCX)

Table 3. Sulfur-containing lipids and PKs with signaling activities.

The bolded compounds are highlighted throughout the section and in Figure 6.

Compound(s) Class Sulfur-containing Group(s) Species Activity Reference(s)
Prunomarin A (40) PK Sulfoxide Phomopsis prunorum (F4–3) Anti-NO production 108
Neosartyrone (41) PK Methylsulfonate Neosartorya udagawae HDN13–313 Anti-lipid accumulation 109
Rubterolone N (42) PK Thiazolidine Actinomadura sp. 5–2 Anti-mPGES1 110
Oxazolismycin (43) PK-NRP Methylthiol Streptomyces griseochromogenes ATCC 14511 Anti-ACE 111
Paraphaeospharides (44, 45) PK-NRP Thioether, Sulfoxide Paraphaeosphaeria negelcta FT462 Anti-NFκB, anti-iNOS 113
Dipenirestone A (46) PK Disulfde Penicillium sp. Anti-PI3K, anti-Akt, anti-mTORC1 107
Sulfobacins (47, 48) Lipid Sulfonate Chryseobacterium gleum DSM16776, Alistipes timonensis DSM27924 LPS displacement from TLR4 114–116
Sulfolipid-1 (49) Lipid Sulfate Mycobacterium tuberculosis Erdman TVRP1 agonist 117

Acknowledgments

This work was supported by National Institutes of Health grants 1R35GM150565 and National Science Foundation grant 2239561. Figures were created using icons from BioRender (https://BioRender.com/dnhunxw).

Footnotes

The authors declare no competing financial interest.

References

  • (1).Atanasov AG; Zotchev SB; Dirsch VM; Orhan IE; Banach M; Rollinger JM; Barreca D; Weckwerth W; Bauer R; Bayer EA; Majeed M; Bishayee A; Bochkov V; Bonn GK; Braidy N; Bucar F; Cifuentes A; D’Onofrio G; Bodkin M; Diederich M; Dinkova-Kostova AT; Efferth T; El Bairi K; Arkells N; Fan T-P; Fiebich BL; Freissmuth M; Georgiev MI; Gibbons S; Godfrey KM; Gruber CW; Heer J; Huber LA; Ibanez E; Kijjoa A; Kiss AK; Lu A; Macias FA; Miller MJS; Mocan A; Müller R; Nicoletti F; Perry G; Pittalà V; Rastrelli L; Ristow M; Russo GL; Silva AS; Schuster D; Sheridan H; Skalicka-Woźniak K; Skaltsounis L; Sobarzo-Sánchez E; Bredt DS; Stuppner H; Sureda A; Tzvetkov NT; Vacca RA; Aggarwal BB; Battino M; Giampieri F; Wink M; Wolfender J-L; Xiao J; Yeung AWK; Lizard G; Popp MA; Heinrich M; Berindan-Neagoe I; Stadler M; Daglia M; Verpoorte R; Supuran CT; the International Natural Product Sciences Taskforce. Natural Products in Drug Discovery: Advances and Opportunities. Nature Reviews Drug Discovery 2021, 20 (3), 200–216. 10.1038/s41573-020-00114-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Pham JV; Yilma MA; Feliz A; Majid MT; Maffetone N; Walker JR; Kim E; Cho HJ; Reynolds JM; Song MC; Park SR; Yoon YJ A Review of the Microbial Production of Bioactive Natural Products and Biologics. Frontiers in Microbiology 2019, Volume 10–2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (3).Hong J Role of Natural Product Diversity in Chemical Biology. Current Opinion in Chemical Biology 2011, 15 (3), 350–354. 10.1016/j.cbpa.2011.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (4).Hai Y; Wei M-Y; Wang C-Y; Gu Y-C; Shao C-L The Intriguing Chemistry and Biology of Sulfur-Containing Natural Products from Marine Microorganisms (1987–2020). Marine Life Science & Technology 2021, 3 (4), 488–518. 10.1007/s42995-021-00101-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).Steele AD; Kiefer AF; Shen B The Many Facets of Sulfur Incorporation in Natural Product Biosynthesis. Current Opinion in Chemical Biology 2023, 76, 102366. 10.1016/j.cbpa.2023.102366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Liu Z; Li M; Wang S; Huang H; Zhang W Sulfur-Containing Metabolites from Marine and Terrestrial Fungal Sources: Origin, Structures, and Bioactivities. Marine Drugs 2022, 20 (12), 765. 10.3390/md20120765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Nwankwo NE; David JC A Review of Sulfur-Containing Compounds of Natural Origin with Insights into Their Pharmacological and Toxicological Impacts. Discover Chemistry 2025, 2 (1), 207. 10.1007/s44371-025-00286-w. [DOI] [Google Scholar]
  • (8).Otwell Anne E; Carr Alex V; Majumder Erica LW; Ruiz Maryann K; Wilpiszeski Regina L; Hoang Linh T; Webb Bill; Turkarslan Serdar; Gibbons Sean M.; Elias Dwayne A.; Stahl David A.; Siuzdak Gary; Baliga Nitin S. Sulfur Metabolites Play Key System-Level Roles in Modulating Denitrification. mSystems 2021, 6 (1), 10.1128/msystems.01025-20. https://doi.org/10.1128/msystems.01025-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Hou Y; Lv B; Du J; Ye M; Jin H; Yi Y; Huang Y Sulfide Regulation and Catabolism in Health and Disease. Signal Transduction and Targeted Therapy 2025, 10 (1), 174. 10.1038/s41392-025-02231-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Russell AH; Truman AW Genome Mining Strategies for Ribosomally Synthesised and Post-Translationally Modified Peptides. Computational and Structural Biotechnology Journal 2020, 18, 1838–1851. 10.1016/j.csbj.2020.06.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (11).Zhong Z; He B; Li J; Li Y-X Challenges and Advances in Genome Mining of Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs). Synthetic and Systems Biotechnology 2020, 5 (3), 155–172. 10.1016/j.synbio.2020.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (12).Wang Z; Yu J; Wang C; Hua Y; Wang H; Chen J The Deep Mining Era: Genomic, Metabolomic, and Integrative Approaches to Microbial Natural Products from 2018 to 2024. Marine Drugs 2025, 23 (7), 261. 10.3390/md23070261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Montalbán-López M; Scott TA; Ramesh S; Rahman IR; Van Heel AJ; Viel JH; Bandarian V; Dittmann E; Genilloud O; Goto Y; Grande Burgos MJ; Hill C; Kim S; Koehnke J; Latham JA; Link AJ; Martínez B; Nair SK; Nicolet Y; Rebuffat S; Sahl H-G; Sareen D; Schmidt EW; Schmitt L; Severinov K; Süssmuth RD; Truman AW; Wang H; Weng J-K; Van Wezel GP; Zhang Q; Zhong J; Piel J; Mitchell DA; Kuipers OP; Van Der Donk WA New Developments in RiPP Discovery, Enzymology and Engineering. Nat. Prod. Rep 2021, 38 (1), 130–239. 10.1039/D0NP00027B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Lagedroste M; Reiners J; Knospe CV; Smits SHJ; Schmitt L A Structural View on the Maturation of Lanthipeptides. Frontiers in Microbiology 2020, Volume 11–2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Ayikpoe RS; van der Donk WA Chapter Eighteen - Peptide Backbone Modifications in Lanthipeptides. In Methods in Enzymology; Petersson EJ, Ed.; Academic Press, 2021; Vol. 656, pp 573–621. 10.1016/bs.mie.2021.04.012. [DOI] [PubMed] [Google Scholar]
  • (16).Chen Y; Wang J; Li G; Yang Y; Ding W Current Advancements in Sactipeptide Natural Products. Frontiers in Chemistry 2021, Volume 9–2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Cao L; Do T; Link AJ Mechanisms of Action of Ribosomally Synthesized and Posttranslationally Modified Peptides (RiPPs). Journal of Industrial Microbiology and Biotechnology 2021, 48 (3–4), kuab005. 10.1093/jimb/kuab005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Dickman R; Mitchell SA; Figueiredo AM; Hansen DF; Tabor AB Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B. J. Org. Chem 2019, 84 (18), 11493–11512. 10.1021/acs.joc.9b01253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Panina I; Taldaev A; Efremov R; Chugunov A Molecular Dynamics Insight into the Lipid II Recognition by Type A Lantibiotics: Nisin, Epidermin, and Gallidermin. Micromachines 2021, 12 (10). 10.3390/mi12101169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Scherer KM; Spille J-H; Sahl H-G; Grein F; Kubitscheck U The Lantibiotic Nisin Induces Lipid II Aggregation, Causing Membrane Instability and Vesicle Budding. Biophysical Journal 2015, 108 (5), 1114–1124. 10.1016/j.bpj.2015.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Ortiz-López FJ; Carretero-Molina D; Sánchez-Hidalgo M; Martín J; González I; Román-Hurtado F; de la Cruz M; García-Fernández S; Reyes F; Deisinger JP; Müller A; Schneider T; Genilloud O Cacaoidin, First Member of the New Lanthidin RiPP Family. Angewandte Chemie International Edition 2020, 59 (31), 12654–12658. 10.1002/anie.202005187. [DOI] [PubMed] [Google Scholar]
  • (22).Deisinger JP; Arts M; Kotsogianni I; Puls J-S; Grein F; Ortiz-López FJ; Martin NI; Müller A; Genilloud O; Schneider T Dual Targeting of the Class V Lanthipeptide Antibiotic Cacaoidin. iScience 2023, 26 (4), 106394. 10.1016/j.isci.2023.106394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Fujinami D; -Mahin A-A; Elsayed KM; Islam MR; Nagao J; Roy U; Momin S; Zendo T; Kohda D; Sonomoto K The Lantibiotic Nukacin ISK-1 Exists in an Equilibrium between Active and Inactive Lipid-II Binding States. Communications Biology 2018, 1 (1), 150. 10.1038/s42003-018-0150-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (24).Vestergaard M; Berglund NA; Hsu P-C; Song C; Koldsø H; Schiøtt B; Sansom MSP Structure and Dynamics of Cinnamycin–Lipid Complexes: Mechanisms of Selectivity for Phosphatidylethanolamine Lipids. ACS Omega 2019, 4 (20), 18889–18899. 10.1021/acsomega.9b02949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (25).Stewart SE; Ashkenazi A; Williamson A; Rubinsztein DC; Moreau K Transbilayer Phospholipid Movement Facilitates the Translocation of Annexin across Membranes. Journal of Cell Science 2018, 131 (14), jcs217034. 10.1242/jcs.217034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (26).Richard AS; Zhang A; Park S-J; Farzan M; Zong M; Choe H Virion-Associated Phosphatidylethanolamine Promotes TIM1-Mediated Infection by Ebola, Dengue, and West Nile Viruses. Proceedings of the National Academy of Sciences 2015, 112 (47), 14682–14687. 10.1073/pnas.1508095112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).Huo L; van der Donk WA Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic. J. Am. Chem. Soc 2016, 138 (16), 5254–5257. 10.1021/jacs.6b02513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).Chen Erquan; Chen Qi; Chen Shaoming; Xu Bing; Ju Jianhua; Wang Huan. Mathermycin, a Lantibiotic from the Marine Actinomycete Marinactinospora Thermotolerans SCSIO 00652. Applied and Environmental Microbiology 2017, 83 (15), e00926–17. 10.1128/AEM.00926-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (29).Vikeli Eleni; Widdick David A.; Batey Sibyl F. D.; Heine Daniel; Holmes Neil A.; Bibb Mervyn J.; Martins Dino J.; Pierce Naomi E.; Hutchings Matthew I.; Wilkinson Barrie. In Situ Activation and Heterologous Production of a Cryptic Lantibiotic from an African Plant Ant-Derived Saccharopolyspora Species. Applied and Environmental Microbiology 2020, 86 (3), e01876–19. 10.1128/AEM.01876-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (30).Singh M; Chaudhary S; Sareen D Roseocin, a Novel Two-Component Lantibiotic from an Actinomycete. Molecular Microbiology 2020, 113 (2), 326–337. 10.1111/mmi.14419. [DOI] [PubMed] [Google Scholar]
  • (31).Xu M; Zhang F; Cheng Z; Bashiri G; Wang J; Hong J; Wang Y; Xu L; Chen X; Huang S-X; Lin S; Deng Z; Tao M Functional Genome Mining Reveals a Class V Lanthipeptide Containing a D-Amino Acid Introduced by an F420H2-Dependent Reductase. Angewandte Chemie International Edition 2020, 59 (41), 18029–18035. 10.1002/anie.202008035. [DOI] [PubMed] [Google Scholar]
  • (32).Grigoreva A; Andreeva J; Bikmetov D; Rusanova A; Serebryakova M; Garcia AH; Slonova D; Nair SK; Lippens G; Severinov K; Dubiley S Identification and Characterization of Andalusicin: N-Terminally Dimethylated Class III Lantibiotic from Bacillus Thuringiensis Sv. Andalousiensis. iScience 2021, 24 (5). 10.1016/j.isci.2021.102480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Karczewski J; Brown CM; Maezato Y; Krasucki SP; Streatfield SJ Efficacy of a Novel Lantibiotic, CMB001, against MRSA. Journal of Antimicrobial Chemotherapy 2021, 76 (6), 1532–1538. 10.1093/jac/dkab040. [DOI] [PubMed] [Google Scholar]
  • (34).Xue D; Shang Z; Older EA; Zhong Z; Pulliam C; Peter K; Nagarkatti M; Nagarkatti P; Li Y-X; Li J Refactoring and Heterologous Expression of Class III Lanthipeptide Biosynthetic Gene Clusters Lead to the Discovery of N,N-Dimethylated Lantibiotics from Firmicutes. ACS Chem. Biol 2023, 18 (3), 508–517. 10.1021/acschembio.2c00849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (35).Xue D; Older EA; Zhong Z; Shang Z; Chen N; Dittenhauser N; Hou L; Cai P; Walla MD; Dong S-H; Tang X; Chen H; Nagarkatti P; Nagarkatti M; Li Y-X; Li J Correlational Networking Guides the Discovery of Unclustered Lanthipeptide Protease-Encoding Genes. Nature Communications 2022, 13 (1), 1647. 10.1038/s41467-022-29325-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (36).Fu Y; Zhou L; Kuipers OP Discovery, Biosynthesis, and Characterization of a Lanthipeptide from Bacillus Subtilis EH11 with a Unique Lanthionine Ring Pattern. Cell Reports Physical Science 2023, 4 (8). 10.1016/j.xcrp.2023.101524. [DOI] [Google Scholar]
  • (37).Thetsana C; Moriuchi R; Kodani S Isolation and Structure Determination of a New Antibacterial Lanthipeptide Derived from the Marine Derived Bacterium Lysinibacillus Sp.CTST325. World Journal of Microbiology and Biotechnology 2025, 41 (2), 54. 10.1007/s11274-024-04212-7. [DOI] [PubMed] [Google Scholar]
  • (38).Zendo T; Ohashi C; Maeno S; Piao X; Salminen S; Sonomoto K; Endo A Kunkecin A, a New Nisin Variant Bacteriocin Produced by the Fructophilic Lactic Acid Bacterium, Apilactobacillus Kunkeei FF30–6 Isolated From Honey Bees. Frontiers in Microbiology 2020, Volume 11–2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (39).Moon K; Xu F; Seyedsayamdost MR Cebulantin, a Cryptic Lanthipeptide Antibiotic Uncovered Using Bioactivity-Coupled HiTES. Angewandte Chemie International Edition 2019, 58 (18), 5973–5977. 10.1002/anie.201901342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (40).Li J; Jin J; Li S; Zhong Y; Jin Y; Zhang X; Xia B; Zhu Y; Guo R; Sun X; Guo J; Hu F; Xiao W; Huang F; Ye H; Li R; Zhou Y; Xiang X; Yao H; Yan Q; Su L; Wu L; Luo T; Liu Y; Guo X; Qin J; Qi H; He J; Wang J; Li Z Tonsillar Microbiome-Derived Lantibiotics Induce Structural Changes of IL-6 and IL-21 Receptors and Modulate Host Immunity. Advanced Science 2022, 9 (30), 2202706. 10.1002/advs.202202706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (41).Barbour A; Smith L; Oveisi M; Williams M; Huang RC; Marks C; Fine N; Sun C; Younesi F; Zargaran S; Orugunty R; Horvath TD; Haidacher SJ; Haag AM; Sabharwal A; Hinz B; Glogauer M Discovery of Phosphorylated Lantibiotics with Proimmune Activity That Regulate the Oral Microbiome. Proceedings of the National Academy of Sciences 2023, 120 (22), e2219392120. 10.1073/pnas.2219392120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (42).Nakatsuji T; Chen TH; Narala S; Chun KA; Two AM; Yun T; Shafiq F; Kotol PF; Bouslimani A; Melnik AV; Latif H; Kim J-N; Lockhart A; Artis K; David G; Taylor P; Streib J; Dorrestein PC; Grier A; Gill SR; Zengler K; Hata TR; Leung DYM; Gallo RL Antimicrobials from Human Skin Commensal Bacteria Protect against Staphylococcus Aureus and Are Deficient in Atopic Dermatitis. Science Translational Medicine 2017, 9 (378), eaah4680. 10.1126/scitranslmed.aah4680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (43).Balty C; Guillot A; Fradale L; Brewee C; Boulay M; Kubiak X; Benjdia A; Berteau O Ruminococcin C, an Anti-Clostridial Sactipeptide Produced by a Prominent Member of the Human Microbiota Ruminococcus Gnavus. Journal of Biological Chemistry 2019, 294 (40), 14512–14525. 10.1074/jbc.RA119.009416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (44).Chiumento S; Roblin C; Kieffer-Jaquinod S; Tachon S; Leprètre C; Basset C; Aditiyarini D; Olleik H; Nicoletti C; Bornet O; Iranzo O; Maresca M; Hardré R; Fons M; Giardina T; Devillard E; Guerlesquin F; Couté Y; Atta M; Perrier J; Lafond M; Duarte V Ruminococcin C, a Promising Antibiotic Produced by a Human Gut Symbiont. Science Advances 5 (9), eaaw9969. 10.1126/sciadv.aaw9969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (45).Shamseddine L; Roblin C; Veyrier I; Basset C; De Macedo L; Boyeldieu A; Maresca M; Nicoletti C; Brasseur G; Kieffer-Jaquinod S; Courvoisier-Dezord É; Amouric A; Carpentier P; Campo N; Bergé M; Polard P; Perrier J; Duarte V; Lafond M Mechanistic and Functional Aspects of the Ruminococcin C Sactipeptide Isoforms. iScience 2023, 26 (9). 10.1016/j.isci.2023.107563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (46).Duarte A. F. de S.; Ceotto-Vigoder H; Barrias ES; Souto-Padrón TCBS; Nes IF; Bastos M. do C. de F. Hyicin 4244, the First Sactibiotic Described in Staphylococci, Exhibits an Anti-Staphylococcal Biofilm Activity. International Journal of Antimicrobial Agents 2018, 51 (3), 349–356. 10.1016/j.ijantimicag.2017.06.025. [DOI] [PubMed] [Google Scholar]
  • (47).Mo T; Ji X; Yuan W; Mandalapu D; Wang F; Zhong Y; Li F; Chen Q; Ding W; Deng Z; Yu S; Zhang Q Thuricin Z: A Narrow-Spectrum Sactibiotic That Targets the Cell Membrane. Angewandte Chemie International Edition 2019, 58 (52), 18793–18797. 10.1002/anie.201908490. [DOI] [PubMed] [Google Scholar]
  • (48).Bushin LB; Covington BC; Rued BE; Federle MJ; Seyedsayamdost MR Discovery and Biosynthesis of Streptosactin, a Sactipeptide with an Alternative Topology Encoded by Commensal Bacteria in the Human Microbiome. J. Am. Chem. Soc 2020, 142 (38), 16265–16275. 10.1021/jacs.0c05546. [DOI] [PubMed] [Google Scholar]
  • (49).Clark KA; Covington BC; Seyedsayamdost MR Biosynthesis-Guided Discovery Reveals Enteropeptins as Alternative Sactipeptides Containing N-Methylornithine. Nature Chemistry 2022, 14 (12), 1390–1398. 10.1038/s41557-022-01063-3. [DOI] [PubMed] [Google Scholar]
  • (50).Hudson GA; Burkhart BJ; DiCaprio AJ; Schwalen CJ; Kille B; Pogorelov TV; Mitchell DA Bioinformatic Mapping of Radical S-Adenosylmethionine-Dependent Ribosomally Synthesized and Post-Translationally Modified Peptides Identifies New Cα, Cβ, and Cγ-Linked Thioether-Containing Peptides. J. Am. Chem. Soc 2019, 141 (20), 8228–8238. 10.1021/jacs.9b01519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (51).Chen Y; Yang Y; Ji X; Zhao R; Li G; Gu Y; Shi A; Jiang W; Zhang Q The SCIFF-Derived Ranthipeptides Participate in Quorum Sensing in Solventogenic Clostridia. Biotechnology Journal 2020, 15 (10), 2000136. 10.1002/biot.202000136. [DOI] [PubMed] [Google Scholar]
  • (52).Torres MDT; Brooks EF; Cesaro A; Sberro H; Gill MO; Nicolaou C; Bhatt AS; de la Fuente-Nunez C Mining Human Microbiomes Reveals an Untapped Source of Peptide Antibiotics. Cell 2024, 187 (19), 5453–5467.e15. 10.1016/j.cell.2024.07.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (53).Zhang J; Zhang D; Xu Y; Zhang J; Liu R; Gao Y; Shi Y; Cai P; Zhong Z; He B; Li X; Zhou H; Chen M; Li Y-X Large-Scale Biosynthetic Analysis of Human Microbiomes Reveals Diverse Protective Ribosomal Peptides. Nat Commun 2025, 16 (1), 3054. 10.1038/s41467-025-58280-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (54).Hirsch P; Tagirdzhanov A; Kushnareva A; Olkhovskii I; Graf S; Schmartz GP; Hegemann JD; Bozhüyük KAJ; Müller R; Keller A; Gurevich A ABC-HuMi: The Atlas of Biosynthetic Gene Clusters in the Human Microbiome. Nucleic Acids Research 2024, 52 (D1), D579–D585. 10.1093/nar/gkad1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (55).Walsh CJ; Guinane CM; O’ Toole PW; Cotter PD A Profile Hidden Markov Model to Investigate the Distribution and Frequency of LanB-Encoding Lantibiotic Modification Genes in the Human Oral and Gut Microbiome. PeerJ 2017, 5, e3254. 10.7717/peerj.3254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (56).Chan DCK; Burrows LL Thiopeptides: Antibiotics with Unique Chemical Structures and Diverse Biological Activities. J Antibiot 2021, 74 (3), 161–175. 10.1038/s41429-020-00387-x. [DOI] [PubMed] [Google Scholar]
  • (57).Schwalen CJ; Hudson GA; Kille B; Mitchell DA Bioinformatic Expansion and Discovery of Thiopeptide Antibiotics. J. Am. Chem. Soc 2018, 140 (30), 9494–9501. 10.1021/jacs.8b03896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (58).Donia MS; Cimermancic P; Schulze CJ; Wieland Brown LC; Martin J; Mitreva M; Clardy J; Linington RG; Fischbach MA A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics. Cell 2014, 158 (6), 1402–1414. 10.1016/j.cell.2014.08.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (59).Chee WJY; Chew SY; Than LTL Vaginal Microbiota and the Potential of Lactobacillus Derivatives in Maintaining Vaginal Health. Microb Cell Fact 2020, 19 (1), 203. 10.1186/s12934-020-01464-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (60).Claesen J; Spagnolo JB; Ramos SF; Kurita KL; Byrd AL; Aksenov AA; Melnik AV; Wong WR; Wang S; Hernandez RD; Donia MS; Dorrestein PC; Kong HH; Segre JA; Linington RG; Fischbach MA; Lemon KP A Cutibacterium Acnes Antibiotic Modulates Human Skin Microbiota Composition in Hair Follicles. Sci. Transl. Med 2020, 12 (570), eaay5445. 10.1126/scitranslmed.aay5445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (61).Chang PT; Rao K; Longo LO; Lawton ES; Scherer G; Van Arnam EB Thiopeptide Defense by an Ant’s Bacterial Symbiont. J. Nat. Prod 2020, 83 (3), 725–729. 10.1021/acs.jnatprod.9b00897. [DOI] [PubMed] [Google Scholar]
  • (62).Bleich R; Watrous JD; Dorrestein PC; Bowers AA; Shank EA Thiopeptide Antibiotics Stimulate Biofilm Formation in Bacillus Subtilis. Proc. Natl. Acad. Sci. U.S.A 2015, 112 (10), 3086–3091. 10.1073/pnas.1414272112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (63).Cameron DM; Thompson J; March PE; Dahlberg AE Initiation Factor IF2, Thiostrepton and Micrococcin Prevent the Binding of Elongation Factor G to the Escherichia Coli Ribosome. Journal of Molecular Biology 2002, 319 (1), 27–35. 10.1016/S0022-2836(02)00235-8. [DOI] [PubMed] [Google Scholar]
  • (64).Harms JM; Wilson DN; Schluenzen F; Connell SR; Stachelhaus T; Zaborowska Z; Spahn CMT; Fucini P Translational Regulation via L11: Molecular Switches on the Ribosome Turned On and Off by Thiostrepton and Micrococcin. Molecular Cell 2008, 30 (1), 26–38. 10.1016/j.molcel.2008.01.009. [DOI] [PubMed] [Google Scholar]
  • (65).Thoendel M; Kavanaugh JS; Flack CE; Horswill AR Peptide Signaling in the Staphylococci. Chem. Rev 2011, 111 (1), 117–151. 10.1021/cr100370n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (66).Olson ME; Todd DA; Schaeffer CR; Paharik AE; Van Dyke MJ; Büttner H; Dunman PM; Rohde H; Cech NB; Fey PD; Horswill AR Staphylococcus Epidermidis Agr Quorum-Sensing System: Signal Identification, Cross Talk, and Importance in Colonization. J Bacteriol 2014, 196 (19), 3482–3493. 10.1128/JB.01882-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (67).Mayville P; Ji G; Beavis R; Yang H; Goger M; Novick RP; Muir TW Structure-Activity Analysis of Synthetic Autoinducing Thiolactone Peptides from Staphylococcus Aureus Responsible for Virulence. Proc. Natl. Acad. Sci. U.S.A 1999, 96 (4), 1218–1223. 10.1073/pnas.96.4.1218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (68).Yang T; Tal-Gan Y; Paharik AE; Horswill AR; Blackwell HE Structure–Function Analyses of a Staphylococcus Epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC-Type Receptor Modulation. ACS Chem. Biol 2016, 11 (7), 1982–1991. 10.1021/acschembio.6b00120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (69).Malone CL; Boles BR; Horswill AR Biosynthesis of Staphylococcus Aureus Autoinducing Peptides by Using the Synechocystis DnaB Mini-Intein. Appl Environ Microbiol 2007, 73 (19), 6036–6044. 10.1128/AEM.00912-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (70).Novick RP; Ross HF; Projan SJ; Kornblum J; Kreiswirth B; Moghazeh S Synthesis of Staphylococcal Virulence Factors Is Controlled by a Regulatory RNA Molecule. The EMBO Journal 1993, 12 (10), 3967–3975. 10.1002/j.1460-2075.1993.tb06074.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (71).Novick RP; Projan SJ; Kornblum J; Ross HF; Ji G; Kreiswirth B; Vandenesch F; Moghazeh S; Novick RP Theagr P2 Operon: An Autocatalytic Sensory Transduction System inStaphylococcus Aureus. Molec. Gen. Genet 1995, 248 (4), 446–458. 10.1007/BF02191645. [DOI] [PubMed] [Google Scholar]
  • (72).Worby CJ; Schreiber HL; Straub TJ; Van Dijk LR; Bronson RA; Olson BS; Pinkner JS; Obernuefemann CLP; Muñoz VL; Paharik AE; Azimzadeh PN; Walker BJ; Desjardins CA; Chou W-C; Bergeron K; Chapman SB; Klim A; Manson AL; Hannan TJ; Hooton TM; Kau AL; Lai HH; Dodson KW; Hultgren SJ; Earl AM Longitudinal Multi-Omics Analyses Link Gut Microbiome Dysbiosis with Recurrent Urinary Tract Infections in Women. Nat Microbiol 2022, 7 (5), 630–639. 10.1038/s41564-022-01107-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (73).Kim HK; Thammavongsa V; Schneewind O; Missiakas D Recurrent Infections and Immune Evasion Strategies of Staphylococcus Aureus. Current Opinion in Microbiology 2012, 15 (1), 92–99. 10.1016/j.mib.2011.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (74).Madhogaria B; Bhowmik P; Kundu A Correlation between Human Gut Microbiome and Diseases. Infectious Medicine 2022, 1 (3), 180–191. 10.1016/j.imj.2022.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (75).Britton RA; Young VB Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium Difficile. Gastroenterology 2014, 146 (6), 1547–1553. 10.1053/j.gastro.2014.01.059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (76).Paharik AE; Parlet CP; Chung N; Todd DA; Rodriguez EI; Van Dyke MJ; Cech NB; Horswill AR Coagulase-Negative Staphylococcal Strain Prevents Staphylococcus Aureus Colonization and Skin Infection by Blocking Quorum Sensing. Cell Host & Microbe 2017, 22 (6), 746–756.e5. 10.1016/j.chom.2017.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (77).Duban M; Cociancich S; Leclère V Nonribosomal Peptide Synthesis Definitely Working Out of the Rules. Microorganisms 2022, 10 (3), 577. 10.3390/microorganisms10030577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (78).Zhang F; Wyche TP; Zhu Y; Braun DR; Yan J-X; Chanana S; Ge Y; Guzei IA; Chevrette MG; Currie CR; Thomas MG; Rajski SR; Bugni TS MS-Derived Isotopic Fine Structure Reveals Forazoline A as a Thioketone-Containing Marine-Derived Natural Product. Org. Lett 2020, 22 (4), 1275–1279. 10.1021/acs.orglett.9b04535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (79).Xue D; Zou H; Qiu Y; Lv W; Madden MD; Xu M; Lian X; Pulliam C; Older EA; Hou L; Campbell A; de Rond T; Awakawa T; Yuan C; Moore BS; Li J Discovery of Acylsulfenic Acid-Featuring Natural Product Sulfenicin and Characterization of Its Biosynthesis. Nature Chemistry 2025, 17 (7), 1011–1019. 10.1038/s41557-025-01833-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (80).Sinha Roy R; M. Gehring A; C. Milne J; J. Belshaw P; T. Walsh C Thiazole and Oxazole Peptides: Biosynthesis and Molecular Machinery. Nat. Prod. Rep 1999, 16 (2), 249–263. 10.1039/A806930A. [DOI] [PubMed] [Google Scholar]
  • (81).Maret W The Extracellular Metallometabolome: Metallophores, Metal Ionophores, and Other Chelating Agents as Natural Products. Natural Product Communications 2024, 19 (8), 1934578X241271701. 10.1177/1934578X241271701. [DOI] [Google Scholar]
  • (82).Foulston L Genome Mining and Prospects for Antibiotic Discovery. Current Opinion in Microbiology 2019, 51, 1–8. 10.1016/j.mib.2019.01.001. [DOI] [PubMed] [Google Scholar]
  • (83).Shen Q; Zhou H; Dai G; Zhong G; Huo L; Li A; Liu Y; Yang M; Ravichandran V; Zheng Z; Tang Y-J; Jiao N; Zhang Y; Bian X Characterization of a Cryptic NRPS Gene Cluster in Bacillus Velezensis FZB42 Reveals a Discrete Oxidase Involved in Multithiazole Biosynthesis. ACS Catal. 2022, 12 (6), 3371–3381. 10.1021/acscatal.1c05131. [DOI] [Google Scholar]
  • (84).Grosse C; Brandt N; Van Antwerpen P; Wintjens R; Matthijs S Two New Siderophores Produced by Pseudomonas Sp. NCIMB 10586: The Anti-Oomycete Non-Ribosomal Peptide Synthetase-Dependent Mupirochelin and the NRPS-Independent Triabactin. Frontiers in Microbiology 2023,Volume 14–2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (85).Do H; Li Z-R; Tripathi PK; Mitra S; Guerra S; Dash A; Weerasekera D; Makthal N; Shams S; Aggarwal S; Singh BB; Gu D; Du Y; Olsen RJ; LaRock C; Zhang W; Kumaraswami M Engineered Probiotic Overcomes Pathogen Defences Using Signal Interference and Antibiotic Production to Treat Infection in Mice. Nature Microbiology 2024, 9 (2), 502–513. 10.1038/s41564-023-01583-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (86).Ko Y-S; Gu D; Lee A; Al Marzooqi D; Zhang W Engineering Escherichia Coli for the Production of the PK/NRP Hybrid Antibiotic Salivabactin. ACS Sustainable Chem. Eng 2025, 13 (27), 10556–10562. 10.1021/acssuschemeng.5c03104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (87).Joyner PM; Liu J; Zhang Z; Merritt J; Qi F; Cichewicz RH Mutanobactin A from the Human Oral Pathogen Streptococcus Mutans Is a Cross-Kingdom Regulator of the Yeast-Mycelium Transition. Org. Biomol. Chem 2010, 8 (24), 5486–5489. 10.1039/C0OB00579G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (88).Wang X; Du L; You J; King JB; Cichewicz RH Fungal Biofilm Inhibitors from a Human Oral Microbiome-Derived Bacterium. Org. Biomol. Chem 2012, 10 (10), 2044–2050. 10.1039/C2OB06856G. [DOI] [PubMed] [Google Scholar]
  • (89).Zvanych R; Lukenda N; Li X; Kim JJ; Tharmarajah S; Magarvey NA Systems Biosynthesis of Secondary Metabolic Pathways within the Oral Human Microbiome Member Streptococcus Mutans. Mol. BioSyst 2015, 11 (1), 97–104. 10.1039/C4MB00406J. [DOI] [PubMed] [Google Scholar]
  • (90).Li Z-R; Sun J; Du Y; Pan A; Zeng L; Maboudian R; Burne RA; Qian P-Y; Zhang W Mutanofactin Promotes Adhesion and Biofilm Formation of Cariogenic Streptococcus Mutans. Nature Chemical Biology 2021, 17 (5), 576–584. 10.1038/s41589-021-00745-2. [DOI] [PubMed] [Google Scholar]
  • (91).Lüthy L; Thies LGS; Beitl KN; Hansen M; McManus J; Afzal M; Schrangl L; Bloch S; Subbiahdoss G; Reimhult E; Schäffer C; Carreira EM Synthesis, Microbiology, and Biophysical Characterization of Mutanofactins from the Human Oral Microbiome. ACS Cent. Sci 2025, 11 (4), 601–611. 10.1021/acscentsci.4c02184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (92).Zipperer A; Konnerth MC; Laux C; Berscheid A; Janek D; Weidenmaier C; Burian M; Schilling NA; Slavetinsky C; Marschal M; Willmann M; Kalbacher H; Schittek B; Brötz-Oesterhelt H; Grond S; Peschel A; Krismer B Human Commensals Producing a Novel Antibiotic Impair Pathogen Colonization. Nature 2016, 535 (7613), 511–516. 10.1038/nature18634. [DOI] [PubMed] [Google Scholar]
  • (93).Bitschar K; Sauer B; Focken J; Dehmer H; Moos S; Konnerth M; Schilling NA; Grond S; Kalbacher H; Kurschus FC; Götz F; Krismer B; Peschel A; Schittek B Lugdunin Amplifies Innate Immune Responses in the Skin in Synergy with Host- and Microbiota-Derived Factors. Nature Communications 2019, 10 (1), 2730. 10.1038/s41467-019-10646-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (94).Park J; Kim J; Hwang S; Oh D; Du YE; Nam S-J; Park H; Lee MJ; Oh D-C Sadopeptins A and B, Sulfoxide- and Piperidone-Containing Cyclic Heptapeptides with Proteasome Inhibitory Activity from a Streptomyces Sp. J. Nat. Prod 2023, 86 (3), 612–620. 10.1021/acs.jnatprod.2c00978. [DOI] [PubMed] [Google Scholar]
  • (95).Wu Q; Bell BA; Yan J-X; Chevrette MG; Brittin NJ; Zhu Y; Chanana S; Maity M; Braun DR; Wheaton AM; Guzei IA; Ge Y; Rajski SR; Thomas MG; Bugni TS Metabolomics and Genomics Enable the Discovery of a New Class of Nonribosomal Peptidic Metallophores from a Marine Micromonospora. J. Am. Chem. Soc 2023, 145 (1), 58–69. 10.1021/jacs.2c06410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (96).Guo J; Zhang Q; Shen Y; Cheng F; Sang M; Wang X; Pan Y; Liu M; Yu H-B; Hu B; Wang S; Zheng L; Geng C; Yang C; Luo L; Zhang G; Du L; Li Y; Zhang W; Zhang Y; Wang B; Li S; Zhang X Deciphering the Thiolactonization Mechanism in Thiolactomycin Biosynthesis. J. Am. Chem. Soc 2025, 147 (26), 22368–22386. 10.1021/jacs.4c14296. [DOI] [PubMed] [Google Scholar]
  • (97).Price AC; Choi K-H; Heath RJ; Li Z; White SW; Rock CO Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin: STRUCTURE AND MECHANISM *. Journal of Biological Chemistry 2001, 276 (9), 6551–6559. 10.1074/jbc.M007101200. [DOI] [PubMed] [Google Scholar]
  • (98).Wyche TP; Piotrowski JS; Hou Y; Braun D; Deshpande R; McIlwain S; Ong IM; Myers CL; Guzei IA; Westler WM; Andes DR; Bugni TS Forazoline A: Marine-Derived Polyketide with Antifungal In Vivo Efficacy. Angewandte Chemie International Edition 2014, 53 (43), 11583–11586. 10.1002/anie.201405990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (99).Lee J-H; Kim E; Choi H; Lee J Collismycin C from the Micronesian Marine Bacterium Streptomyces Sp. MC025 Inhibits Staphylococcus Aureus Biofilm Formation. Marine Drugs 2017, 15 (12). 10.3390/md15120387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (100).Kawatani M; Muroi M; Wada A; Inoue G; Futamura Y; Aono H; Shimizu K; Shimizu T; Igarashi Y; Takahashi-Ando N; Osada H Proteomic Profiling Reveals That Collismycin A Is an Iron Chelator. Scientific Reports 2016, 6 (1), 38385. 10.1038/srep38385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (101).Fan Y; Ma Z; Zhang Y; Wang Y; Ding Y; Wang C; Cao S Sulfur-Containing Compounds from Endophytic Fungi: Sources, Structures and Bioactivities. Journal of Fungi 2022, 8 (6), 628. 10.3390/jof8060628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (102).Zhang F; Kong F-D; Ma Q-Y; Xie Q-Y; Zhou L-M; Zhao Y-X; Guo L Polyketides with Quorum Sensing Inhibitory Activity from the Marine-Derived Fungus Aspergillus Sp. ZF-79. Journal of Asian Natural Products Research 2020, 22 (11), 999–1005. 10.1080/10286020.2019.1670647. [DOI] [PubMed] [Google Scholar]
  • (103).Kuźniak E; Gajewska E Lipids and Lipid-Mediated Signaling in Plant–Pathogen Interactions. International Journal of Molecular Sciences 2024, 25 (13), 7255. 10.3390/ijms25137255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (104).Pulliam C; Hou L; Xue D; Xu M; Holandez-Lopez K; Li J A Bacterial Sulfotransferase Catalyzes an Unusual Di-Sulfation in Natural Products Biosynthesis. ChemBioChem 2025, 26 (11), e202500024. 10.1002/cbic.202500024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (105).Ma M; Lohman JR; Liu T; Shen B C-S Bond Cleavage by a Polyketide Synthase Domain. Proceedings of the National Academy of Sciences 2015, 112 (33), 10359–10364. 10.1073/pnas.1508437112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (106).Radka CD; Miller DJ; Frank MW; Rock CO Biochemical Characterization of the First Step in Sulfonolipid Biosynthesis in Alistipes Finegoldii. Journal of Biological Chemistry 2022, 298 (8). 10.1016/j.jbc.2022.102195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (107).Han M-Q; Zhao Y-J; Pang S; Zhu H-J; Luo D-Q; Liu Y-F; Yang K; Cao F Modulating Culture Method Promotes the Production of Disulfide-Linked Resorcylic Acid Lactone Dimers with Anti-Proliferative Activity. Bioorganic Chemistry 2025, 159, 108418. 10.1016/j.bioorg.2025.108418. [DOI] [PubMed] [Google Scholar]
  • (108).Zhang X-Q; Lu Z-H; Xia G-R; Song W-M; Guo Z-Y; Proksch P (+)-/(−)-Prunomarin A and (+)-Pestalactone B, Three New Isocoumarin Derivatives from the Endophytic Fungus Phomopsis Prunorum. Tetrahedron Letters 2021, 75, 153205. 10.1016/j.tetlet.2021.153205. [DOI] [Google Scholar]
  • (109).Yu G; Wang Q; Liu S; Zhang X; Che Q; Zhang G; Zhu T; Gu Q; Li D Methylsulfonylated Polyketides Produced by Neosartorya Udagawae HDN13–313 via Exogenous Addition of Small Molecules. J. Nat. Prod 2019, 82 (4), 998–1001. 10.1021/acs.jnatprod.9b00035. [DOI] [PubMed] [Google Scholar]
  • (110).Guo H; Benndorf R; König S; Leichnitz D; Weigel C; Peschel G; Berthel P; Kaiser M; Steinbeck C; Werz O; Poulsen M; Beemelmanns C Expanding the Rubterolone Family: Intrinsic Reactivity and Directed Diversification of PKS-Derived Pyrans. Chemistry – A European Journal 2018, 24 (44), 11319–11324. 10.1002/chem.201802066. [DOI] [PubMed] [Google Scholar]
  • (111).Pan Y; Jiang G; Huang C; Zhao H Discovery and Characterization of Oxazolismycin, an Oxazole-Containing Natural Product with an Atypical Loading Mechanism. JACS Au 2025, 5 (7), 3000–3007. 10.1021/jacsau.5c00326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (112).Li C-S; Ding Y; Yang B-J; Miklossy G; Yin H-Q; Walker LA; Turkson J; Cao S A New Metabolite with a Unique 4-Pyranone–γ-Lactam–1,4-Thiazine Moiety from a Hawaiian-Plant Associated Fungus. Org. Lett 2015, 17 (14), 3556–3559. 10.1021/acs.orglett.5b01650. [DOI] [PubMed] [Google Scholar]
  • (113).Li C-S; Sarotti AM; Huang P; Dang UT; Hurdle JG; Kondratyuk TP; Pezzuto JM; Turkson J; Cao S NF-κB Inhibitors, Unique γ-Pyranol-γ-Lactams with Sulfide and Sulfoxide Moieties from Hawaiian Plant Lycopodiella Cernua Derived Fungus Paraphaeosphaeria Neglecta FT462. Sci Rep 2017, 7 (1), 10424. 10.1038/s41598-017-10537-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (114).Hou L; Tian H-Y; Wang L; Ferris ZE; Wang J; Cai M; Older EA; Raja MRK; Xue D; Sun W; Nagarkatti P; Nagarkatti M; Chen H; Fan D; Tang X; Li J Identification and Biosynthesis of Pro-Inflammatory Sulfonolipids from an Opportunistic Pathogen Chryseobacterium Gleum. ACS Chem. Biol 2022, 17 (5), 1197–1206. 10.1021/acschembio.2c00141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (115).Older EA; Zhang J; Ferris ZE; Xue D; Zhong Z; Mitchell MK; Madden M; Wang Y; Chen H; Nagarkatti P; Nagarkatti M; Fan D; Ellermann M; Li Y-X; Li J Biosynthetic Enzyme Analysis Identifies a Protective Role for TLR4-Acting Gut Microbial Sulfonolipids in Inflammatory Bowel Disease. Nat Commun 2024, 15 (1), 9371. 10.1038/s41467-024-53670-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (116).Older EA; Mitchell Mary K.; Campbell Andrew; Lian Xiaoying; Madden Michael; Wang Yuzhen; van de Wal Lauren E.; Zaw Thelma; VanderVeen Brandon N.; Tatum Rodney; Murphy E. Angela; Chen Yan-Hua; Fan Daping; Ellermann Melissa; and Li J Human Gut Commensal Alistipes Timonensis Modulates the Host Lipidome and Delivers Anti-Inflammatory Outer Membrane Vesicles to Suppress Colitis in an Il10-Deficient Mouse Model. Gut Microbes 2025, 17 (1), 2517380. 10.1080/19490976.2025.2517380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (117).Ruhl CR; Pasko BL; Khan HS; Kindt LM; Stamm CE; Franco LH; Hsia CC; Zhou M; Davis CR; Qin T; Gautron L; Burton MD; Mejia GL; Naik DK; Dussor G; Price TJ; Shiloh MU Mycobacterium Tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough. Cell 2020, 181 (2), 293–305.e11. 10.1016/j.cell.2020.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (118).Chen H-Y; Liu T-K; Shi Q; Yang X-L Sesquiterpenoids and Diterpenes with Antimicrobial Activity from Leptosphaeria Sp. XL026, an Endophytic Fungus in Panax Notoginseng. Fitoterapia 2019, 137, 104243. 10.1016/j.fitote.2019.104243. [DOI] [PubMed] [Google Scholar]
  • (119).Ying Z; Li X-M; Yang S-Q; Li H-L; Li X; Wang B-G; Meng L-H Pseudallenes A and B, New Sulfur-Containing Ovalicin Sesquiterpenoid Derivatives with Antimicrobial Activity from the Deep-Sea Cold Seep Sediment-Derived Fungus Pseudallescheria Boydii CS-793. Beilstein J. Org. Chem 2024, 20, 470–478. 10.3762/bjoc.20.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (120).Liu Y-P; Fang S-T; Wang B-G; Ji N-Y Phenol Derivatives from the Cold-Seep Fungus Aspergillus Sydowii 10–31. Phytochemistry Letters 2022, 52, 63–66. 10.1016/j.phytol.2022.09.007. [DOI] [Google Scholar]
  • (121).Castellano I; Seebeck FP On Ovothiol Biosynthesis and Biological Roles: From Life in the Ocean to Therapeutic Potential. Nat. Prod. Rep 2018, 35 (12), 1241–1250. 10.1039/C8NP00045J. [DOI] [PubMed] [Google Scholar]
  • (122).Francioso A; Baseggio Conrado A; Mosca L; Fontana M Chemistry and Biochemistry of Sulfur Natural Compounds: Key Intermediates of Metabolism and Redox Biology. Oxidative Medicine and Cellular Longevity 2020, 2020, 1–27. 10.1155/2020/8294158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (123).Luccarini A; Zuccarotto A; Galeazzi R; Morresi C; Masullo M; Castellano I; Damiani E Insights on the UV-Screening Potential of Marine-Inspired Thiol Compounds. Marine Drugs 2023, 22 (1), 2. 10.3390/md22010002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (124).Castellano I; Di Tomo P; Di Pietro N; Mandatori D; Pipino C; Formoso G; Napolitano A; Palumbo A; Pandolfi A Anti-Inflammatory Activity of Marine Ovothiol A in an In Vitro Model of Endothelial Dysfunction Induced by Hyperglycemia. Oxidative Medicine and Cellular Longevity 2018, 2018 (1), 2087373. 10.1155/2018/2087373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (125).Salaheldin AT; Shehata MR; Sakr HI; Atia T; Mohamed AS Therapeutic Potency of Ovothiol A on Ethanol-Induced Gastric Ulcers in Wistar Rats. Marine Drugs 2022, 21 (1), 25. 10.3390/md21010025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (126).Yin J; Zhang C; Huang J; Zhang J; Liu D; Huang J; Proksch P; Lin W Violaceimides A–E, Sulfur-Containing Metabolites from a Sponge-Associated Fungus Aspergillus Violaceus. Tetrahedron Letters 2018, 59 (33), 3157–3160. 10.1016/j.tetlet.2018.05.085. [DOI] [Google Scholar]
  • (127).Cong M; Ren X; Song Y; Pang X; Tian X; Liu Y; Guo P; Wang J Ochrathinols A and B, Two Pairs of Sulfur-Containing Racemates from an Antarctic Fungus Aspergillus Ochraceopetaliformis SCSIO 05702 Inhibit LPS-Induced pro-Inflammatory Cytokines and NO Production. Phytochemistry 2023, 208, 113593. 10.1016/j.phytochem.2023.113593. [DOI] [PubMed] [Google Scholar]
  • (128).Henriksen NNSE; Lindqvist LL; Wibowo M; Sonnenschein EC; Bentzon-Tilia M; Gram L Role Is in the Eye of the Beholder—the Multiple Functions of the Antibacterial Compound Tropodithietic Acid Produced by Marine Rhodobacteraceae. FEMS Microbiology Reviews 2022, 46 (3), fuac007. 10.1093/femsre/fuac007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (129).Dittmann KK; Porsby CH; Goncalves P; Mateiu RV; Sonnenschein EC; Bentzon-Tilia M; Egan S; Gram L Tropodithietic Acid Induces Oxidative Stress Response, Cell Envelope Biogenesis and Iron Uptake in Vibrio Vulnificus. Environ Microbiol Rep 2019, 11 (4), 581–588. 10.1111/1758-2229.12771. [DOI] [PubMed] [Google Scholar]
  • (130).Beyersmann PG; Tomasch J; Son K; Stocker R; Göker M; Wagner-Döbler I; Simon M; Brinkhoff T Dual Function of Tropodithietic Acid as Antibiotic and Signaling Molecule in Global Gene Regulation of the Probiotic Bacterium Phaeobacter Inhibens. Sci Rep 2017, 7 (1), 730. 10.1038/s41598-017-00784-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES